Comparison

TGF-βRI inhibitor 3 European Partner

Item no. HY-137918
Manufacturer MedChem Express
CASRN 666729-57-3
Amount 1 ea
Specific against other
Citations [1]Shimizu T, et al. Synthesis and evaluation of [2-(4-quinolyloxy)phenyl]methanone derivatives: novel selective inhibitors of transforming growth factor-beta kinase. J Med Chem. 2008 Jun 12;51(11):3326-9.
Smiles CC(C1=CC(C)=C(C)C=C1OC2=CC=NC3=CC(OC)=C(OC)C=C23)=O
Shipping condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Targets
Anaplastic lymphoma kinase (ALK); Src; TGF-β Receptor
Shipping Temperature
Room temperature
Molecular Weight
351.40
Product Description
TGF-βRI inhibitor 3 (Compound 9ac) is a selective TGF-β inhibitor. TGF-βRI inhibitor 3 can effectively inhibit the TGF-β signaling pathway. TGF-βRI inhibitor 3 has IC 50 values of 13 μM and 0.63 μM for c-Src kinase and ALK5 kinase, respectively [1] .
Manufacturer - Research Area
Others
Manufacturer - Pathway
Protein Tyrosine Kinase/RTK; TGF-beta/Smad
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close